These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 325836)

  • 1. Suppression of T-cell-mediated immune responses by sodium cyanate.
    Nehlsen SL; Lalezari P
    Transplant Proc; 1977 Mar; 9(1):997-1000. PubMed ID: 325836
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective immunosuppression by drugs in balanced immune responses.
    Heppner GH; Griswold DE; Di Lorenzo J; Poplin EA; Calabresi P
    Fed Proc; 1974 Aug; 33(8):1882-5. PubMed ID: 4602113
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell-mediated immunity and aging.
    Stutman O
    Fed Proc; 1974 Sep; 33(9):2028-32. PubMed ID: 4153574
    [No Abstract]   [Full Text] [Related]  

  • 4. Potentiation of T-cell mediated immunity by levamisole.
    Renoux G; Renoux M; Teller MN; McMahon S; Guillaumin JM
    Clin Exp Immunol; 1976 Aug; 25(2):288-96. PubMed ID: 782749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of cyclosporine on in situ cellular and humoral immune responses during allograft rejection.
    Orosz CG; Sirinek LP; Zinn NE; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1175-7. PubMed ID: 3274303
    [No Abstract]   [Full Text] [Related]  

  • 6. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 7. Marked suppression of cell-mediated immunity with niridazole: first report.
    Mahmoud AA; Warren KS; Mandel MA
    Surg Forum; 1974; 25(0):514-6. PubMed ID: 4612800
    [No Abstract]   [Full Text] [Related]  

  • 8. Testing immunological responses to experimental allografts.
    Hamburger J; Debray-Sachs M; Dimitriu A; Dy M; Caraux J
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):85-91. PubMed ID: 4280168
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of niridazole in cellular immunity in vivo and in vitro.
    Solbach W; Wagner H; Röllinghoff M
    Clin Exp Immunol; 1978 Jun; 32(3):411-8. PubMed ID: 357051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of cell-mediated immunity in the mouse following administration of 4-nitroquinoline 1-oxide.
    Outzen HC; Prehn RT
    Cancer Res; 1973 Feb; 33(2):408-10. PubMed ID: 4569790
    [No Abstract]   [Full Text] [Related]  

  • 11. Graft-versus-host-induced immunosuppression. The effect of antigenic stimulation on cell-mediated and humoral immune responses.
    Treiber W; Lapp WS
    Transplantation; 1973 Sep; 16(3):211-6. PubMed ID: 4147031
    [No Abstract]   [Full Text] [Related]  

  • 12. The in vivo activity of in vitro immunized mouse thymocytes. II. Rejection of skin allografts and graft-vs-host activity.
    Rouse BT; Wagner H
    J Immunol; 1972 Dec; 109(6):1282-9. PubMed ID: 4404454
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell-mediated hyperacute rejection. VII. Suppression by irradiation.
    Eichwald EJ; Jorgensen C
    Transplantation; 1984 Aug; 38(2):191-2. PubMed ID: 6380046
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of ICRF 159 on immune responses.
    Hellmann K
    Proc R Soc Med; 1972 Mar; 65(3):264-5. PubMed ID: 4563302
    [No Abstract]   [Full Text] [Related]  

  • 15. FTY720 inhibits TH1-mediated allogeneic humoral immune response.
    Peñuelas-Rivas G; Domínguez-Perles R; Brinkmann V; Del Rio ML; Muñoz-Luna A; Ramírez-Romero P; Parrilla-Paricio P; Rodríguez-Barbosa JI
    Transplant Proc; 2005 Nov; 37(9):4124-6. PubMed ID: 16386642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressor cell activation by anti-thy 1.2 in NZB/WF1 mice.
    Klassen LW; Zarate A; Gelfand MC; Steinberg AD
    J Immunol; 1977 Dec; 119(6):2067-72. PubMed ID: 334981
    [No Abstract]   [Full Text] [Related]  

  • 17. Devising murine models to better adapt clinical protocols: sequential low-dose treatment with anti-CD3 and anti-CD4 monoclonal antibodies to prevent fully mismatched allograft rejection.
    Campos HH; Bach JF; Chatenoud L
    Transplant Proc; 1993 Feb; 25(1 Pt 1):798-9. PubMed ID: 8438486
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental cutaneous leishmaniasis: VI: anergy and allergy in the cellular immune response during non-healing infection in different strains of mice.
    Preston PM; Behbehani K; Dumonde DC
    J Clin Lab Immunol; 1978 Nov; 1(3):207-19. PubMed ID: 387961
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhanced primary resistance to Listeria monocytogenes in T cell-deprived mice.
    Chan C; Kongshavn PA; Skamene E
    Immunology; 1977 Apr; 32(4):529-37. PubMed ID: 415965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of recipient immune reactivity pretransplantation: correlation of T cell reactivity with allograft rejection.
    Thomas FT; Thomas JM; Mendez-Picon G; Wolf JS; Lee HM
    Surg Forum; 1976; 27(62):298-300. PubMed ID: 798324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.